Yp. Liu et al., METALLOTHIONEIN-I-TRANSGENIC MICE ARE NOT PROTECTED FROM ACUTE CADMIUM-METALLOTHIONEIN-INDUCED NEPHROTOXICITY, Toxicology and applied pharmacology, 137(2), 1996, pp. 307-315
Mice pretreated with Zn have increased renal metallothionein (MT) leve
ls and are protected from CdMT nephrotoxicity. To determine whether MT
is important in this Zn-induced protection against CdMT-induced nephr
otoxicity, MT-transgenic mice that have high levels of MT in their kid
neys (10-fold over control mice) have been studied to determine whethe
r they are resistant to CdMT-induced nephrotoxicity. Mice were injecte
d with CdMT (0.1-0.6 mg Cd/kg, iv) and kidney injury was evaluated 24
hr later. CdMT produced renal toxicity in a dose-dependent manner. At
a nephrotoxic dose of CdMT (0.4 mg Cd/kg), urinary protein and glucose
excretion were increased 30- and 60-fold, respectively, in control mi
ce. However, similar increases in protein and glucose excretion were a
lso observed in MT-transgenic mice, CdMT also induced a similar dose-d
ependent proximal tubular cell necrosis in both control and MT-transge
nic mice in a dose-dependent manner. Treatment of control mice with Zn
(100 mu mol/kg, sc x 2 days) increased renal MT to levels similar to
those of untreated MT-transgenic mice and protected against CdMT-induc
ed renal injury. Furthermore, when Zn (25-100 mu mol/kg, sc) was given
immediately before CdMT injection (i.e., without preinduction of MT),
it was still effective in preventing CdMT nephrotoxicity. We conclude
that Zn-induced protection against CdMT nephrotoxicity does not appea
r to be due to induction of renal MT. (C) 1996 Academic Press, Inc.